Guiyang Xintian Pharmaceutical Co.,Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 177.32 million compared to CNY 208.76 million a year ago. Revenue was CNY 177.32 million compared to CNY 208.76 million a year ago.

Net income was CNY 15.57 million compared to CNY 25.09 million a year ago. Basic earnings per share from continuing operations was CNY 0.0673 compared to CNY 0.1082 a year ago. Diluted earnings per share from continuing operations was CNY 0.0622 compared to CNY 0.1021 a year ago.